Approval of study design by French ANSM and Ethics Committee Recruitment of 12 patients expected to start in Q4 2023 in 4 French centers First study results expected in mid-2024 Endocarditis is an ...
NANTES, France--(BUSINESS WIRE)--Regulatory News: Pherecydes Pharma (FR0011651694 - ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated ...
Vision – To be the world's leading and most trusted provider of information and services that will make a real difference in clinical practice and improve outcomes for patients. Mission – To lead the ...
Background. Staphylococcus lugdunensis is an emerging cause of endocarditis. To cause endovascular infections, S. lugdunensis requires mechanisms to overcome shear stress. We investigated whether ...
Endocarditis is a rare, potentially fatal infection of the endocardium, or inner lining of the heart. It is usually caused by bacteria traveling through the bloodstream to the heart and is treated by ...
New data on infective endocarditis (IE) among people who inject drugs run counter to long-held stereotypes about the condition—for example, a sizeable proportion of cases affect the heart’s left side, ...
Infectious endocarditis (IE) represents a severe medical condition marked by infectious inflammation of the heart's inner tissues, primarily affecting the valves. Despite its relative rarity, IE's ...
In the July 15 issue of The Journal of Clinical Investigation, Ambrose Cheung and colleagues at Dartmouth School of Medicine in New Hampshire, USA, report that salicylic acid (SAL), the major ...
Staphylococcus aureus infection can lead to the development of serious conditions such as endocarditis, pneumonia, and septicemia and requires intensive antibiotic therapy. The emergence of S. aureus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results